A comparative analysis of recurrence risk predictions in ER+/HER2- early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast. Gunda A, Eshwaraiah MS, Gangappa K, Kaur T, et al. Breast Cancer Res Treat 2022 Sep 10. pii: 10.1007/s10549-022-06729.

Read + Share

Amedeo Smart

Independent Medical Education